Sun Pharma Advanced Research Company Limited

NSE:SPARC.NS

207.44 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q3
Revenue 128.6168.1165.6138.6211.8239.5396.91,310.9315.4284.6252.389621.5278.7219.9280.571218.1176.41,854.5227.044196171.9173.2848.292198.8613.5168.1200.9194.2153.6233.9416230.5948.9214.8411.7335.5431.2434.4426.975312.8459.1358.5425.697629.5258.4356.7718.2942.248.563.842.16545.1
Cost of Revenue 499.5619.3605.6327.4246.8421.5640.7358.6328.8387.7398.671258.7309.7275.7353.317409.7609.7691.3714.339312362.8543.1572.474449.8246.6335.4165.1433406.8629.7399.2548.9488.7273.6271.7530.2337.1245.1308.095320.5285.4290.7-332.921128.6181.1103.3-294.246133.1150104.3-328.245106.5
Gross Profit -370.9-451.2-440-188.8-35-182-243.8952.3-13.4-103.1-146.282362.8-31-55.8-72.746-191.6-433.31,163.2-487.295-116-190.9-369.9275.818-251366.9-167.335.8-238.8-253.2-395.816.8-318.4460.2-58.8140-194.794.1189.3118.88-7.7173.767.8758.618500.977.3253.41,012.536-90.9-101.5-40.5370.41-61.4
Gross Profit Ratio -2.884-2.684-2.657-1.362-0.165-0.76-0.6140.726-0.042-0.362-0.580.584-0.111-0.254-0.259-0.878-2.4560.627-2.146-0.592-1.111-2.1360.325-1.2630.598-0.9950.178-1.23-1.648-1.6920.04-1.3810.485-0.2740.34-0.580.2180.4360.278-0.0250.3780.1891.7820.7960.2990.711.41-2.154-2.093-0.6358.785-1.361
Reseach & Development Expenses 255.3185.4224.5237.1182.1369.8582.9308.1273330.7334.9222256.2247340.3353.8568628.92,844.752262.9318.9441.72,405.213403.7226.1306.61,955.173380.6397.1475.81,947.738462.139601,275.056479.5274.7215.51,079.736288265.9272.3988.489102.1166.678.2723.54500000
General & Administrative Expenses 0220294.1398.2418.8413.5338.7426.9237.5316.4204.427154.9211.1149145.8411692.6164.9158.509116.871.492.5101.033188.5103.7167.1461.90300000000000000016.70600015.09900000
Selling & Marketing Expenses 0108.4130.400000000000000000000000255.16000000000000000106.51000122.60200000
SG&A 434.5328.4424.5398.2418.8413.5338.7426.9237.5316.4204.427154.9211.1149145.8411692.6164.9158.509116.871.492.5101.033188.5103.7167.1717.063246.8265.2248197.538218.9224.10160.355134.2136.2136.5120.239115112.6111.3123.216107.7108.2104.4137.70100000
Other Expenses 015.64463.984.9101.9107.30.30.61.8-65.4293.459.88-46.0891628.26.6-66.097.122.636.7-81.49132.945.712.35.221.49.912.337.428.640.429.923.25.52.12.1-28.2759.36.814.2-75.78321.230.422-8.2843.421.8-5.7965.4
Operating Expenses 689.8513.8649869911.5870.8761.3821.8642.6705.9535.845501.3546.1512.2457.564465.6418.2583.2478.25443.6460.8602.8345.893472438.3489.6505.9363.1382.2404.4376.6373.2348.9321.9246214.5272207.4212.695190.1194.7178.8811.556156.8163.5156.2559.39141.1134.4143.3590.987122.4
Operating Income -1,060.7-965-1,089-993.9-861.6-950.9-817.8130.8-655.4-809-690.5-138.5-577.1-568-530.31-657.2-851.5580-965.545-559.6-651.7-972.7-70.075-723-71.4-656.9-470.1-601.9-635.4-800.2-359.8-691.6111.3-380.7-106-409.2-177.9-18.1-93.815-197.8-21-111-52.938344.1-86.297.2453.146-232-235.9-183.8-220.577-183.8
Operating Income Ratio -8.248-5.741-6.576-7.171-4.068-3.97-2.060.1-2.078-2.843-2.736-0.223-2.071-2.583-1.89-3.013-4.8270.313-4.253-2.855-3.791-5.616-0.083-3.637-0.116-3.908-2.34-3.099-4.137-3.421-0.865-30.117-1.772-0.257-1.22-0.413-0.042-0.22-0.632-0.046-0.31-0.1240.547-0.3340.2720.631-5.498-4.864-2.881-5.231-4.075
Total Other Income Expenses Net -111034.9-2.6-2.6-2.6-2.1-29.3-28.6-14.5-20-19.925.7-45.7-36.878-1916.6-13.1-29.8894.520.130.8-23.43332.845.612.1494.921.29.711.837.128.336.116.610.2-10.51.6-0.1858.76.313.621.48129.7-2.1-12.793-8.9-5.30.64.6564.8
Income Before Tax -1,071.7-955-1,054.1-996.5-864.2-953.5-819.9101.5-684-823.5-710.454-158.4-551.4-613.7-567.188-676.2-834.9566.9-995.434-555.1-631.6-941.9-93.508-690.2-25.8-644.824.8-580.7-625.7-788.4-322.7-663.3147.4-364.1-95.8-410.2-177.4-16.5-94-189.1-14.7-97.4-31.458356.1-76.595.1440.353-240.9-241.2-183.2-215.921-179
Income Before Tax Ratio -8.334-5.681-6.365-7.19-4.08-3.981-2.0660.077-2.169-2.894-2.815-0.255-1.978-2.791-2.022-3.1-4.7330.306-4.384-2.832-3.674-5.438-0.11-3.472-0.042-3.8360.123-2.99-4.074-3.371-0.776-2.8780.155-1.695-0.233-1.223-0.411-0.038-0.22-0.605-0.032-0.272-0.0740.566-0.2960.2670.613-5.709-4.973-2.871-5.121-3.969
Income Tax Expense 1.643.831.6431.67830.95829.34531.27329.9141.82.1873.459.883.3251628.26.6-14.147.122.636.7-96.4063345.712.35.221.49.912.537.428.640.429.923.25.52.12.10.2989.36.814.2-6.446.430.4225.9133.421.85.3975.4
Net Income -1,073.3-959-1,057.9-996.5-864.2-953.5-819.9101.5-684-823.5-710.454-158.4-551.4-613.7-567.188-676.2-834.9566.9-995.434-555.1-631.6-941.9-93.508-690.2-25.8-644.824.8-580.7-625.7-788.4-322.7-663.3147.4-364.1-95.8-410.2-177.4-16.5-94-189.1-14.7-97.4-25.058309.7-76.595.1440.353-240.9-241.2-183.2-215.921-179
Net Income Ratio -8.346-5.705-6.388-7.19-4.08-3.981-2.0660.077-2.169-2.894-2.815-0.255-1.978-2.791-2.022-3.1-4.7330.306-4.384-2.832-3.674-5.438-0.11-3.472-0.042-3.8360.123-2.99-4.074-3.371-0.776-2.8780.155-1.695-0.233-1.223-0.411-0.038-0.22-0.605-0.032-0.272-0.0590.492-0.2960.2670.613-5.709-4.973-2.871-5.121-3.969
EPS -3.31-2.96-3.26-3.07-2.66-2.94-2.550.37-2.52-3.03-2.69-0.6-2.09-2.34-2.17-2.58-3.192.16-3.8-2.12-2.41-3.59-0.36-2.72-0.1-2.570.1-2.34-2.53-3.19-1.32-2.690.61-1.47-0.4-1.73-0.75-0.07-0.36-0.79-0.06-0.41-0.0961.3-0.320.41.68-1.06-1.14-0.86-0.82-0.84
EPS Diluted -3.31-2.96-3.26-3.07-2.66-2.94-2.550.35-2.52-3.03-2.67-0.6-2.09-2.34-2.16-2.58-3.192.16-3.8-2.12-2.41-3.59-0.36-2.72-0.1-2.570.1-2.34-2.53-3.19-1.32-2.690.61-1.47-0.4-1.73-0.75-0.07-0.36-0.79-0.06-0.41-0.0961.3-0.320.41.68-1.06-1.14-0.86-0.82-0.84
EBITDA -1,028.7-933.6-1,058.3-962.3-829.8-919.9-788.4162.1-625.4-780.2-663.148-109.3-491.9-534.7-500.952-613.6-795.5614.4-952.38-530-606.6-913.5-148.357-671-6.3-625.6-444.7-560.3-604.7-767.1-301.6-642.1172.8-331.2-63.2-384.6-156.92.2-75.721-170.56.4-80.8-20.562374.3-46.8128467.614-220-225.4-173.7-207.057-170.4
EBITDA Ratio -7.999-5.554-6.391-6.943-3.918-3.841-1.9860.124-1.983-2.741-2.627-0.176-1.765-2.432-1.785-2.813-4.510.331-4.195-2.704-3.529-5.274-0.175-3.375-0.01-3.722-2.214-2.885-3.937-3.28-0.725-2.7860.182-1.542-0.154-1.146-0.3640.005-0.177-0.5450.014-0.225-0.0480.595-0.1810.3590.651-5.213-4.647-2.723-4.911-3.778